FDA Clears Neuromodulation Device for Acute Migraine Pain medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
https://www.afinalwarning.com/499507.html (Natural News) Few things can derail a person’s day like a bad headache or migraine, and over-the-counter remedies often provide little relief. However, scientific studies are now pointing to cannabis as a potential solution for this common and frustrating problem.
One particularly promising study, which was led by Carrie Cuttler Of
Washington State University, is the first one to use data from migraine and headache patients using cannabis as a treatment in real time; past studies were restricted to asking patients to recall the effects of past cannabis use.
Cutler said her team decided to perform the study because a significant number of people have said they use cannabis to relieve migraines and headaches but very few studies existed looking into the topic.
Share
Theranica, an Israeli prescription digital therapeutics developer for migraine and other pain conditions, has received 510(k) clearance from the U.S. Food and Drug Administration for its Nerivio device.
The device has been cleared for acute treatment of episodic or chronic migraine in people 12 years and older.
Nerivio is a wireless, noninvasive remote electrical-stimulation wearable that is worn on the upper arm at the onset of a migraine. Each treatment session is 45 minutes long and uses remote electrical neuromodulation to activate the brain s native conditioned pain modulation mechanism to treat pain and associated migraine symptoms.
Users control the device with an accompanying app that can adjust the stimulation intensity, monitor the treatment duration and pause or stop treatment if needed. Within the app, users can track their migraines using a diary feature that records treatment sessions, pain levels and related symptoms. From there, users can share their mig
Dural Arteriovenous Fistulas Treatment Market 2021 - Investment Strategy, Outlook and Key Development till 2023 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Amgen and Novartis
It took meeting a college classmate who had been diagnosed with migraine for Karamo Brown, a cast member of the Netflix show
Queer Eye, to realize there was a name and diagnosis for the debilitating headaches he’d been experiencing since he was a teenager. It clicked for me, says Brown, now 40. “I was like, ‘Oh, you can actually go to the doctor for this, you can talk to somebody? Oh, my gosh!’ And also, ‘I’m not alone with this feeling? You’re feeling exactly what I’m feeling?’” he recalls.
Unfortunately, Brown’s experience is not unusual. The majority of people with migraine never seek medical care for their pain, and more than half of people with migraine are never diagnosed, according to the Migraine Research Foundation.